Takayasu Arteritis clinical trials

The registry lists 78 studies for Takayasu Arteritis across more than 10 countries. 32 are recruiting or about to start. 49 of them are mainly about Takayasu Arteritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Takayasu Arteritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Recruiting: 24
Status unknown: 12
Not yet recruiting: 8
Active, not recruiting: 3
Terminated: 2

Phase

Phase 2: 9
Phase 4: 9
Phase 3: 7
Early Phase 1: 1

Where

China: 25
United States: 20
Canada: 8
Turkey: 8
United Kingdom: 7
France: 6

Who runs them

Shanghai Zhongshan Hospital (7) · University of Pennsylvania (6) · Assistance Publique - Hôpitaux de Paris (6) · Chinese SLE Treatment And Research Group (5) · University of South Florida (5) · Peking Union Medical College Hospital (3) · Marmara University (2) · University of Sao Paulo General Hospital (2)

What is being tested here

Drugs under test in Takayasu Arteritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Adalimumab	4	0	4
Tofacitinib	3	1	4
Tocilizumab	2	1	4
Infliximab	1	0	3
Secukinumab	1	0	1
Ivarmacitinib	1	0	1
Pirfenidone	1	0	1
Deucravacitinib	1	0	1
Certolizumab Pegol	1	0	1
Bosentan	1	0	1

Drug classes tested here JAK inhibitors 5 open · Tyrosine kinase inhibitors (TKIs) 5 open

Coming up

2phase 3 studies under way

5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Dec 2026A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA) · Beijing Institute of Heart, Lung and Blood Vessel Diseases
Dec 2026Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement · China-Japan Friendship Hospital
Mar 2027Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis · University of Edinburgh
Jul 2027Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) · University of Edinburgh
Aug 2027EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases · Assistance Publique - Hôpitaux de Paris

Who these studies take

Of the 24 Takayasu Arteritis studies recruiting now, 12 (50%) set no upper age limit and 10 (42%) stop at 75 or younger. 10 (42%) take children under 18. 1 (4%) are for women only and 0 (0%) for men only; 6 (25%) take healthy volunteers.

Recruiting studies that take each age, of 24
Age	Women	Men
10	8 (33%)	8 (33%)
18	24 (100%)	23 (96%)
30	23 (96%)	22 (92%)
40	23 (96%)	22 (92%)
50	23 (96%)	22 (92%)
65	21 (88%)	21 (88%)
75	14 (58%)	14 (58%)
85	13 (54%)	13 (54%)

Across all 78 studies, recruiting or not: 35% stop at 75 or younger and 27% at 65; 37% take children; 1% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 78. Browse all 78 → or search them.